Pelham推出血液透析TPU导管

2012-04-10 范振光 生意社

  总部设在美国的Phase One Medical公司近日宣布正在进行新的医疗器械的研发,目前公司已与Pelham Plastics公司签订协议,进行新型血液透析导管批量生产。     新型血液透析导管的材料是由热塑性聚氨酯(TPU)、聚碳酸酯等组成。在病人进行血液透析时,为病人血管提供长期高流速的通道,并能保证低回流性能,使得血液不会倒流。新的设计采用了先进的流体动力学平衡和稳定

  总部设在美国的Phase One Medical公司近日宣布正在进行新的医疗器械的研发,目前公司已与Pelham Plastics公司签订协议,进行新型血液透析导管批量生产。     新型血液透析导管的材料是由热塑性聚氨酯(TPU)、聚碳酸酯等组成。在病人进行血液透析时,为病人血管提供长期高流速的通道,并能保证低回流性能,使得血液不会倒流。新的设计采用了先进的流体动力学平衡和稳定流动机制,使得血液在流动的过程中能够尽量减少并发症。     这种新型导管预计在2013年初将获得FDA(美国食品药物管理局)的批准。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1725413, encodeId=a0781e254134e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Jan 15 22:36:00 CST 2013, time=2013-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262448, encodeId=5214126244825, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625817, encodeId=0cd5162581e51, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2013-01-15 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1725413, encodeId=a0781e254134e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Jan 15 22:36:00 CST 2013, time=2013-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262448, encodeId=5214126244825, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625817, encodeId=0cd5162581e51, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 habb
  3. [GetPortalCommentsPageByObjectIdResponse(id=1725413, encodeId=a0781e254134e, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Jan 15 22:36:00 CST 2013, time=2013-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262448, encodeId=5214126244825, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1625817, encodeId=0cd5162581e51, content=<a href='/topic/show?id=bc29140196e' target=_blank style='color:#2F92EE;'>#PEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14019, encryptionId=bc29140196e, topicName=PEL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=399320916411, createdName=tidiq, createdTime=Thu Apr 12 14:36:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 tidiq

相关资讯

AJKD:研究显示低钠浓度透析液对血液透析患者的影响

近日,国际杂志American Journal of Kidney Diseases在线刊登了国外研究人员的最新研究成果“Effect of Lowering Dialysate Sodium Concentration on Interdialytic Weight Gain and Blood Pressure in Patients Undergoing Thrice-Weekly In-c

ACEI和ARB对透析患者的影响

    血管紧张素转换酶(ACEI)和血管紧张素受体阻断剂(ARB)可以减少总人口中的心血管疾病的死亡率,但它们对血液透析患者的影响还没有深入研究。为了研究ACEI和ARB对响血液透析患者氧化应激、炎症反应和纤维蛋白溶解的影响,美国田纳西州范德堡大学医学中心的Jorge L. Gamboa开展了一项随机、双盲、安慰剂控制的3×3交叉研究。   &nbs

低钠浓度透析液对一周三次夜间血液透析患者的影响

文献标题:Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: a quality improvement stud

维持性血液透析患者严重跌倒的发生、并发症及危险因素

    我们中心所有维持性血液透析(MHD)的患者参加了此调查,首先进行基准的行为导向的流动性评估试验(POMA)及跌倒风险因素纪录。 我们把急诊入院的摔伤定义为严重摔伤并记录在案。       入组患者共有84名(平均年龄69.5岁,最小26岁,最大85岁),透析前POMA分数低(中位数20,最高26,最低5),20.6个月(142.2病人年

夜间长时间血液透析对尿毒症患者营养状态的影响

    最近,第二军医大学附属长征医院肾内科、解放军肾脏病研究所的研究人员的一项研究显示,夜间长时间血液透析(INHD)能提高维持性血液透析患者的食欲和膳食摄入量,且能降低患者血磷水平,较好地改善患者营养状态,具有良好的应用前景。该研究发表于2012年第1期《中华肾脏病杂志》。       该研究旨在观察夜间长时间血液透析(INHD)对尿毒症患